Holy Stone Healthcare Co., Ltd. (TPEX:4194)
Taiwan · Delayed Price · Currency is TWD 7.10
-0.03 (-0.42%)
Jan 22, 2026, 1:11 PM CST
Holy Stone Healthcare Revenue
Holy Stone Healthcare had revenue of 47.51M TWD in the twelve months ending June 30, 2025, down -78.63% year-over-year. In the year 2024, Holy Stone Healthcare had annual revenue of 118.77M, down -49.86%.
Revenue (ttm)
47.51M
Revenue Growth
-78.63%
P/S Ratio
21.91
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 118.77M | -118.12M | -49.86% |
| Dec 31, 2023 | 236.89M | -33.35M | -12.34% |
| Dec 31, 2022 | 270.24M | 53.16M | 24.49% |
| Dec 31, 2021 | 217.08M | -4.51M | -2.04% |
| Dec 31, 2020 | 221.60M | 17.44M | 8.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Level Biotechnology | 753.30M |
| Meribank Biotech | 486.52M |
| Taiwan Advance Bio-Pharmaceutical | 371.86M |
| TCI GENE | 324.73M |
| BioLASCO Taiwan | 277.12M |
| GeneReach Biotechnology | 215.32M |
| Lukas Biomedical | 180.32M |
| NatureWise Biotech & Medicals | 180.29M |